These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10495357)

  • 1. Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development.
    Goekjian PG; Jirousek MR
    Curr Med Chem; 1999 Sep; 6(9):877-903. PubMed ID: 10495357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C inhibitors.
    Swannie HC; Kaye SB
    Curr Oncol Rep; 2002 Jan; 4(1):37-46. PubMed ID: 11734112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol.
    Koide K; Bunnage ME; Gomez Paloma L; Kanter JR; Taylor SS; Brunton LL; Nicolaou KC
    Chem Biol; 1995 Sep; 2(9):601-8. PubMed ID: 9383464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology evaluation: ISIS-3521.
    Li K; Zhang J; Sirois P; Hu Y
    Curr Opin Mol Ther; 1999 Jun; 1(3):393-8. PubMed ID: 11713804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
    Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
    Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen.
    Hanauske AR; Sundell K; Lahn M
    Curr Pharm Des; 2004; 10(16):1923-36. PubMed ID: 15180529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
    Meinhardt G; Roth J; Totok G
    Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro.
    Qatsha KA; Rudolph C; Marmé D; Schächtele C; May WS
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4674-8. PubMed ID: 7685108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C inhibitors as novel anticancer drugs.
    Goekjian PG; Jirousek MR
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2117-40. PubMed ID: 11772309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells.
    Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A
    Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKC activators (phorbol ester or bryostatin) stimulate outgrowth of NGF-dependent neurites in a subline of PC12 cells.
    Burry RW
    J Neurosci Res; 1998 Jul; 53(2):214-22. PubMed ID: 9671978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
    Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
    J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
    Luo W; Sharif TR; Houghton PJ; Sharif M
    Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C targeting in antineoplastic treatment strategies.
    Jarvis WD; Grant S
    Invest New Drugs; 1999; 17(3):227-40. PubMed ID: 10665476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysmorphogenic effects of a specific protein kinase C inhibitor during neurulation.
    Ward KW; Rogers EH; Hunter ES
    Reprod Toxicol; 1998; 12(5):525-34. PubMed ID: 9763244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): potential role in breast cancer.
    Roychowdhury D; Lahn M
    Semin Oncol; 2003 Apr; 30(2 Suppl 3):30-3. PubMed ID: 12722024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha.
    Clarke H; Ginanni N; Laughlin KV; Smith JB; Pettit GR; Mullin JM
    Exp Cell Res; 2000 Nov; 261(1):239-49. PubMed ID: 11082294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes.
    Yoo J; Nichols A; Song JC; Mammen J; Calvo I; Worrell RT; Cuppoletti J; Matlin K; Matthews JB
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G703-12. PubMed ID: 12505880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different sensitivities of neutrophil responses to a selective protein kinase C inhibitor Ro 31-8425; redundancy in signal transduction.
    Merritt JE; Sullivan JA; Tse J; Wilkinson Se; Nixon JS
    Cell Signal; 1997 Jan; 9(1):53-7. PubMed ID: 9067630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.